CN114832045A - 一种治疗痛风的药物组合物及其制备方法和用途 - Google Patents
一种治疗痛风的药物组合物及其制备方法和用途 Download PDFInfo
- Publication number
- CN114832045A CN114832045A CN202210040885.2A CN202210040885A CN114832045A CN 114832045 A CN114832045 A CN 114832045A CN 202210040885 A CN202210040885 A CN 202210040885A CN 114832045 A CN114832045 A CN 114832045A
- Authority
- CN
- China
- Prior art keywords
- parts
- pain
- pharmaceutical composition
- medicine
- gout
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000005569 Gout Diseases 0.000 title claims abstract description 31
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 11
- 238000002360 preparation method Methods 0.000 title claims description 6
- 239000003814 drug Substances 0.000 claims abstract description 39
- 239000000203 mixture Substances 0.000 claims abstract description 13
- 241000124033 Salix Species 0.000 claims abstract description 12
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 10
- 244000111489 Gardenia augusta Species 0.000 claims abstract description 10
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 9
- 241001407382 Berberis julianae Species 0.000 claims abstract description 9
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 9
- 229940116229 borneol Drugs 0.000 claims abstract description 9
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 9
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 9
- QQILFGKZUJYXGS-UHFFFAOYSA-N Indigo dye Chemical compound C1=CC=C2C(=O)C(C3=C(C4=CC=CC=C4N3)O)=NC2=C1 QQILFGKZUJYXGS-UHFFFAOYSA-N 0.000 claims abstract description 5
- 244000061520 Angelica archangelica Species 0.000 claims abstract description 4
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 4
- 244000299790 Rheum rhabarbarum Species 0.000 claims abstract 3
- 208000002193 Pain Diseases 0.000 claims description 47
- 230000008961 swelling Effects 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 210000004369 blood Anatomy 0.000 claims description 11
- 239000008280 blood Substances 0.000 claims description 11
- 230000000694 effects Effects 0.000 claims description 11
- 230000001154 acute effect Effects 0.000 claims description 7
- 208000026137 Soft tissue injury Diseases 0.000 claims description 6
- 206010003246 arthritis Diseases 0.000 claims description 6
- 208000014674 injury Diseases 0.000 claims description 6
- 230000000740 bleeding effect Effects 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 4
- 230000008736 traumatic injury Effects 0.000 claims description 4
- 230000017531 blood circulation Effects 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 230000001737 promoting effect Effects 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 3
- 208000034656 Contusions Diseases 0.000 claims 1
- 208000034526 bruise Diseases 0.000 claims 1
- 230000007774 longterm Effects 0.000 abstract description 2
- 230000003285 pharmacodynamic effect Effects 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 description 23
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 23
- 238000011282 treatment Methods 0.000 description 19
- 239000004575 stone Substances 0.000 description 18
- 208000024891 symptom Diseases 0.000 description 15
- 210000003423 ankle Anatomy 0.000 description 12
- 210000002683 foot Anatomy 0.000 description 11
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 8
- 201000001431 Hyperuricemia Diseases 0.000 description 7
- 210000001503 joint Anatomy 0.000 description 7
- 239000002674 ointment Substances 0.000 description 7
- 206010017076 Fracture Diseases 0.000 description 6
- 241000219061 Rheum Species 0.000 description 6
- 210000000544 articulatio talocruralis Anatomy 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 241000213006 Angelica dahurica Species 0.000 description 5
- 208000010392 Bone Fractures Diseases 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 210000003414 extremity Anatomy 0.000 description 5
- 239000008187 granular material Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000000399 orthopedic effect Effects 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 229940097275 indigo Drugs 0.000 description 4
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 4
- 239000004973 liquid crystal related substance Substances 0.000 description 4
- 238000005507 spraying Methods 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 210000003371 toe Anatomy 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 230000009278 visceral effect Effects 0.000 description 4
- 235000018958 Gardenia augusta Nutrition 0.000 description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 3
- 230000002159 abnormal effect Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000002414 leg Anatomy 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 229940116269 uric acid Drugs 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010018634 Gouty Arthritis Diseases 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 235000003805 Musa ABB Group Nutrition 0.000 description 2
- 240000008790 Musa x paradisiaca Species 0.000 description 2
- 235000015266 Plantago major Nutrition 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 210000001142 back Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 230000007937 eating Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000008407 joint function Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000008447 perception Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 208000030090 Acute Disease Diseases 0.000 description 1
- 208000009304 Acute Kidney Injury Diseases 0.000 description 1
- 241001270131 Agaricus moelleri Species 0.000 description 1
- 241001083847 Berberis Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 208000008924 Femoral Fractures Diseases 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010023203 Joint destruction Diseases 0.000 description 1
- 208000034693 Laceration Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000006670 Multiple fractures Diseases 0.000 description 1
- 208000002565 Open Fractures Diseases 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010034246 Pelvic fractures Diseases 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 241001522129 Pinellia Species 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000033626 Renal failure acute Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- 240000001745 Rheum palmatum Species 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 208000024248 Vascular System injury Diseases 0.000 description 1
- 208000012339 Vascular injury Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 208000026816 acute arthritis Diseases 0.000 description 1
- 201000011040 acute kidney failure Diseases 0.000 description 1
- 208000012998 acute renal failure Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000004380 ashing Methods 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000002302 brachial artery Anatomy 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 210000001513 elbow Anatomy 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 210000003811 finger Anatomy 0.000 description 1
- 210000001145 finger joint Anatomy 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 210000000610 foot bone Anatomy 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000009395 genetic defect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000000474 heel Anatomy 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 208000037808 hypertension grade 2 Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 208000018937 joint inflammation Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000002818 limb ischemia Diseases 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000000878 metatarsophalangeal joint Anatomy 0.000 description 1
- 238000013188 needle biopsy Methods 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000002832 shoulder Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000005065 subchondral bone plate Anatomy 0.000 description 1
- 208000013460 sweaty Diseases 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 231100000216 vascular lesion Toxicity 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 210000000596 ventricular septum Anatomy 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/76—Salicaceae (Willow family), e.g. poplar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种治疗痛风的羌医药物组合物,它包括如下质量配比的组分:生大黄50‑70份、三颗针5‑15份、柳树嫩枝60‑100份、白芷根70‑90份、栀子40‑60份、冰片1‑3份、青黛10‑20份。发明人通过多年经验,经过长期不断探索、尝试,开创性的使用柳树嫩枝入药,并发现将柳树嫩枝、栀子、冰片三者合用后,可以在减少组分种类的情况下,仍然保持良好的药效活性,有效降低了用药成本。
Description
技术领域
本发明涉及民族药物领域。
背景技术
痛风是一种遗传缺陷性疾病,具有遗传倾向,因此对于家族中有痛风史的人,应注意有患痛风的可能,这就是说,先天因素------遗传,是判断某人是否易患痛风的主要原因。但一些后天的内外因素,对痛风的发生也有影响。
痛风引起的关节红肿热痛及关节炎;跌扑引起的瘀肿疼痛、急性软组织损伤;无名肿痛多有后遗症等以其致残率、致死率高且治疗难度大,这一类疾病是当今医学界公认的疑难杂症。
羌医称上述诸病为“火石病”。火石病系指脏腑内伤、肢体筋脉失养,而致肢体赛米管道堵塞化火,出现红肿热痛等主要临床表现的一种病证。本病名最早见于《戈馹巴莫玉禾喆》、《依基岐伯姆思贝》、《依基责思》、《依基岐伯》、《祚穆·羌医世家临床经验录》手抄本中提出“石病、“火石病”、“堵塞”、“血脉枯竭”、“骨石病”。
发明内容
羌医理论指出:人体赛米管道中白石滋部、黑石滋部、的功能混乱后产生的火毒石,火毒石不在体内正常运转排泄,而是在体内不断恶性循环,火毒石不断堆积在血管和内脏器官里,堵塞了正常运行的管道,从而使血液水等异常所致,其中异常黑石液水、火毒液晶、黑火毒液晶等异常毒液是主要致病毒体液。人的生命活动靠保质保量的各种营养物质,也就是由机体莫斯(气)、萨(血)滋(水)、吉纳(精微物质)、以及苏莫斯(本气)”来控制。人食用各种高脂肪、高蛋白等营养物质后,在正常情况下脾胃和肝肾肺通过机体莫斯(气)、萨(血)滋(水)、吉纳(精微物质)、以及苏莫斯(本气)”作用下,按照人体各部位和管道赛米的所需把营养物质输送到全身。脾胃和肝肾赛米萨喜居器官功能失调,火毒石不断堆积在血管和内脏器官里,堵塞了正常运行的管道,表情面红目赤、灰暗、痛苦面容,脚趾疼痛不堪,痛不欲生,发作时伴有发热、汗多、头痛、心悸等症状。好发年龄20—58岁的男性,女性与男性相比少一些。羌医把莫饶依基(痛风、高尿酸血症)分一下3型:
1)黑石液水型:肢节痛疼,屈伸不利,春夏季节和盛秋季节容易发病,痛处皮肤颜色暗红,摸之不烫手背,遇冰而痛加,痛如闪电而不固定,得温度则痛减。舌苔厚白,脉浮而迟,耳色不润,指节位灰暗不明。
2)火毒液晶型:关节红肿变形,形如馍馍(馒头),痛疼剧烈,手背检测触摸发烫温高不下,通不可摸,风过变痛,遇冰则舒,遇热加痛,有口干出汗,无法入睡,人烦操不安,心烦意乱,有些见舌苔黑厚有些舌红无苔,有些舌苔黄厚或黄燥刮之有生,脉快而面上,有些快而滑动。耳色红中见紫色。
3)黑火毒液晶型:关节痛疼如针刺刀割,痛有定处,轻按则痛,皮肤晦暗,有瘀堵塞滞,有火石块形成,关节畸形,僵硬,舌强质紫暗,脉撞时停3秒。
莫饶依基(痛风)在羌医第二代就有明确的理论和临床诊断标准,以症状描述和症状表现为依据,长期运用于临床,为广大老百姓服务。
指导理论,源自羌族先贤对宇宙天体的感悟,对天地人和谐的感知,对自然万物(包括人类)生命源头—阿博喏克萨(白石神)的崇拜。羌医传人通过跨越两个多世纪的共同努力,以释比文化哲学思想为领,结合上古羌人欧·特峚用白石补天,白石生火,石生水,水生万物等论述中总结并提出“石病学”,接纳和创新了ㄙㄨㄙㄚ(苏卅,羌医辩算学),在“饶·依基”(石病学)、“赛米萨喜居·依基”(赛米管道学)、“革日杭”(四相学)、“尼核砒石依基”(黑白学)、(三间学) “峚苏·德尔思”(生命学)、“禾朵尔牟合·克尔嘎”(六脏八腑)等羌医核心理论指导下,再结合中医药学的病理病因的理论认识,通过临床实践--理论--实践地反复提升,将治疗凸索·克斯尔哈尔饶依基的理论建立完善,并传承至今经久未衰,且至今每年为数千计的患者带来福音,在传统医学被越来越多的患者所信赖的二十一世纪,具有不可替代的巨大潜力。
为了解决痛风问题,本发明提供了一种治疗痛风的羌医药物组合物,它包括如下质量配比的组分:
生大黄50-70份、三颗针5-15份、柳树嫩枝60-100份、白芷根70-90份、栀子40-60份、冰片1-3份、青黛10-20份。
方中刷格禾(生大黄)为羌医莫·思贝(天药),有退火解毒、消肿止痛,凉血止血,活血散瘀主药。而鉌扎哈(三颗针)斯尔思福恰勒(柳树嫩枝) 托活尼果博(白芷根)为羌医勒·思贝(地药)三味羌药协助天药增强了退火解毒、消肿止痛,凉血止血,活血散瘀,同时具有化石散结、疏通赛米管道。卡斯茹(栀子)滋巴厄雪(冰片)为羌医莫色·思贝(太阳药)此两味药的加入增强了处方中“天药、地药、太阳药、月亮药”的团队合作精神和团队合作的力量,快速制约天药、地药的不足。哈则卓(青黛)为羌医旭始·思贝(月亮药)具有带领处方配伍中的全药,引导走到疾病处所,从而消除赛米萨喜居管道中细微之石,达到羌医白黑平衡,精神乃至。
本方是主要治疗痛风引起的关节红肿热痛及关节炎;跌扑引起的瘀肿疼痛、急性软组织损伤;无名肿痛,疗效确切的方药。通过两百余年的使用,再经第六、七代羌医三十余年的临床应用、病例回访及羌医羌药专家多次论证认为:“白黑脉通液”的临床疗效肯定。由于“火石病”的治疗周期相对长,反复发作率高,一般需要1~7个月左右,中药及羌药汤药很难让患者坚持服药。为方便患者使用和携带方便,将该方制成外用羌药液(药酒),便于患者使用、携带和保存,使患者能长期坚持外用喷涂而不中断治疗。经临床应用,“白黑脉通液”(本发明药物组合物)使用、携带方便,性能稳定,
质量可控,宜保存等优点。
本发明还提供了上述的药物组合物在制备治疗痛风或痛风所致的关节红肿热痛或关节炎的产品中的用途。
本发明还提供了上述的药物组合物在制备具有消肿止痛、凉血止血、活血散瘀、疏通赛米管道功效的产品中的用途。
本发明还提供了上述的药物组合物在制备治疗跌扑引起的瘀肿疼痛、急性软组织损伤、无名肿痛的产品中的用途。
本发明产品选自外用制剂,可以制备成粉剂、酒剂、膏剂、搽剂、凝胶剂、巴布剂等等。
研究还发现,再上述病症中还可能存在如下两种情况:
1.多褥膜(休克)常见于多发性骨折、股骨骨折、骨盆骨折、脊柱骨折和严重开放性骨折,常因广泛的软组织损伤、大量出血、剧烈疼痛以及内脏损伤而引起多褥膜(休克)。
2.萨喜居德乌(血管损伤)肩部骨折损伤腋窝血管,肘部骨折损伤肱动脉,股骨骨折损伤股动脉、股静脉等等。这是常见病,都会引起肢体的血供障碍。不仅免去了患者不少的痛苦,尤其以骨伤科为主的急症患者治疗及时完全能够减少后遗症的发生,预后好,疗效好。羌医不仅注重疾病本身,更着重于患者本身的情志、心态,结合羌医传统的辨算施治,打通内部赛米管道,从而使得病人以积极乐观的心态配合治疗,减少疾病对患者身心的干扰。
从现代医学角度来看,骨折患者一般不用药物治疗自身恢复,在漫长的病程中易伴发周围血管病变和神经病变,随之引起肢端缺血、骨痂生长缓慢或骨不生长等问题出现,由于患肢赛米萨喜居管道淤堵,血液循环畅,愈合极为困难。
使用本发明药物组合物可以有效避免或降低上述情况的发生。
发明人前期还有一治疗痛风的羌药组合物,大黄18份、三颗针8.8份、三颗针刺5.9份、青黛5.6份、石墨4.3份、栀子14.6份、半夏4.4份、白芷18份、赤芍8.6份、车前子13.5 份、车前草4份、蒲公英12.4份和花椒1.7份,该组合物亦具有良好的治疗作用。然而,美中不足的是,该组合物成分较多,用药成本较高。在此基础上,发明人通过多年经验,经过长期不断探索、尝试,开创性的使用柳树嫩枝入药,并发现将柳树嫩枝、栀子、冰片三者合用后,可以在减少组分种类的情况下,仍然保持良好的药效活性,有效降低了用药成本。
具体实施方式
实施例1
取生大黄600g三颗针100g柳树嫩枝800g白芷根800栀子500冰片10g青黛 150g。将上述药材粉碎,制备成粉剂。使用时,喷以75%乙醇,润湿后,贴敷于患处。
实施例2
取生大黄500g三颗针200g柳树嫩枝1000g白芷根700栀子600冰片15g青黛200g。将上述药材粉碎成大粒径颗粒,使用50%乙醇浸泡,得到酒剂,使用时,喷涂于患处,并辅以膏剂或乙醇润湿后敷贴。
实施例3
取生大黄700g三颗针50g柳树嫩枝600g白芷根600栀子400冰片5g青黛 100g。将上述药材饮片,使用75%乙醇回流提取,收集提取液,浓缩后,加入适当辅料,制备膏剂。
下面结合实施例对本发明进一步说明。
病症的发作一般一下几项:
1)常午夜起病,突然发作,因疼痛而惊醒,受累关节红、肿、热、剧痛和功能障碍,大多 27h内症状达到高峰。
2)最常见为第一跖趾关节(约60—85%),其他部位依次为足底、踝、足跟、膝、腕、指、肘、肩、耳等关节。
3)全身表现:常有发热、血白细胞增高,血沉增快。
4)关节液和痛风石针吸活检有尿酸盐结晶。
5)急性发作诱因:受寒、劳累、饮酒、多肉食生活、食入高蛋白、高嘌呤饮食、穿紧鞋、外伤、手术、感染、服用激素药等。
6)间歇期急性期缓解之后,患者全无症状,称为间歇期,此期可持续数月或数年。
7)慢性痛风急性发作,随着病情的延长,发作次数频繁,受累关节增多,疼痛时间延长,缓解速度减慢。
8)慢性期以预防急性关节炎复发、纠正高尿酸血症、预防尿酸盐结晶沉积造成关节破坏及肾脏损害。
9)痛风是一种遗传缺陷性疾病,具有遗传倾向。
10)血液检查:有尿酸性结石形成时,尿中可出现红细胞和尿酸盐结晶。尿酸盐结晶阻塞尿路引起急性肾功能衰竭时,24h尿尿酸/肌酐常>1.0。
11)CT与MRI检查沉积在关节内的痛风石,根据其灰化程度的不同在CT扫描中表现为灰度不等的斑点状影像。
12)当关节软骨消失,软骨下骨质侵蚀和关节周围组织浸润,造成渐进性病残时,少数重症者在几年之内,即可产生巨大的痛风石和关节的严重破坏。
符合以上羌医标准1、2、4、5、6中任何一个条件者即可诊断为羌医莫饶依基(痛风、高尿酸血症)。
本发明的临床治疗情况:
患者人群:痛风患病一般男性居多,女性偏少,好发年龄集中在19—70岁。从2021年一年门诊收治病人中统计患者383例其中男性293例,女性90例,年龄20-70岁,病程1天到60年,有反复发作的100例。
用药方式:采取外敷为主,内服为辅的治疗给药方式。
评价标准:采用羌医临床症状表现的程度、红肿热痛的等级、生化指标、DR、CT、MRI等量表测定患者痛风、高尿酸血症分值,同时利用生化指标、DR、CT、MRI等侧定患者痛风、高尿酸血症的变化。观察痛风、高尿酸血症患者生化指标、DR、CT、MRI等的改变与脚趾尿酸盐结晶堆积的变化以及羌医综合治疗对其影响。
治疗效果分为治愈、好转和无效三种情况,其中:
治愈:症状全部消失,功能活动恢复正常,主要理化检查指标正常。
好转:1)显效:全部症状消除或主要症状消除,关节功能基本恢复,能参加正常工作和劳动能够自理,或者失去工作和劳动能力。
2)有效:主要症状基本消除,主要关节功能基本恢复,生活基本能够自理。
无效:和治疗前后相比较,各方面均无进步。
治疗效果:患者用药时间跨度为2周-6月,临床数据统计治愈273例,好转107例,无效3例,治愈率约71.3%,有效率达99%[(治愈+好转)/总数]。
典型病例:
谢某某,男,70岁,(2021年3月6日)右小腿足踝足背肿胀疼痛伸屈及行走功能障碍2+月余,患者不明原因出现左足背足趾红肿热痛即在成都市多家医院治疗无效,出院来我羌医骨科治疗,患者扶双拐入诊室,检查:左小腿踝关节足趾红肿胀压痛,触摸疼痛剧烈,裤脚边摩擦均有剧烈疼痛感,足踝屈伸试验(+++)。诊断:左小腿足踝足背趾骨痛风性关节炎。采用本发明酒剂外喷红肿疼痛部位,外敷本发明组合物膏剂,绷带包扎。每6天换药一次。运用羌医石病学、三间学、赛米管道、六脏八腑学等理论指导,告述患者遵照医嘱:忌酒、忌生冷、忌发物、避风寒,3月21日患者复诊,自述上3次治疗后,诸症消失,巩固治疗,今治疗继续外喷酒剂治疗,外敷膏剂绷带包扎。患者在我羌医骨科复诊五次连续治疗1月余后,疼痛症状消退,左踝关节功能、足背关节功能恢复,行走自如。建议继续内服内服化石消毒颗粒(九味羌药化石消毒颗粒)2月调理,患者已经临床痊愈。
江某某,女,61岁,右小腿足踝足背肿胀疼痛伸屈及行走功能障碍2+月余,患者不明原因出现左足背足趾红肿热痛即在成都市郫县人民医院住院治疗无效,出院来我羌医骨科治疗,患者扶双拐入诊室,检查:右小腿踝关节足趾红肿胀压痛,触摸疼痛,足踝屈伸试验(+), 2014年8月13日四川省成都市郫县人民医院检验报告提示:1、尿微量淡白119mg/L高,2、尿酸410。诊断:1、高血压2级2、痛风3、慢性肝炎4、肾功能不全5、室间隔增厚6、颈腰椎退变。采用本发明酒剂外喷红肿疼痛部位,外敷本发明组合物膏剂,绷带包扎。每6天换药一次。自述上2次治疗后,疼痛症状消失,触摸压迫疼痛消退,可以丢弃双拐行走,今治疗继续外喷酒剂治疗,外敷膏剂绷带包扎。患者在我羌医骨科连续治疗50天后,疼痛症状消退,左踝关节功能、足背关节功能恢复,行走自如。建议继续内服内服化石消毒颗粒(九味羌药化石消毒颗粒)2月调理,患者已经临床痊愈。
李某,男,39岁,双足掌骨红肿热痛跳痛1+月,一月以来,在多处医治,无效,更加重病症,诊断:双足痛风性关节炎合并撕裂性骨折兼软组织损伤。采用本发明酒剂外喷红肿疼痛部位,外敷本发明组合物膏剂,绷带包扎。患者在我羌医骨科连续治疗19天后,双踝关节肿胀疼痛明显减轻,持续治疗4月疼痛症状消退,双侧踝关节功能、足背关节功能恢复,行走自如痊愈。
Claims (9)
1.一种治疗痛风的羌医药物组合物,其特征在于,它包括如下质量配比的组分:生大黄50-70份、三颗针5-15份、柳树嫩枝60-100份、白芷根70-90份、栀子40-60份、冰片1-3份、青黛10-20份。
2.根据权利要求1所述的组合物,其特征在于,它包括如下质量配比的组分:生大黄60份、三颗针10份、柳树嫩枝80份、白芷根80份、栀子50份、冰片1份、青黛15份。
3.根据权利要求1或2所述的组合物,其特征在于:所述组合物为外用制剂。
4.权利要求1或2所述药物组合物的制备方法,其特征在于:各组分的药粉,混匀即可。
5.权利要求1或2所述药物组合物的制备方法,其特征在于:取各组分,用乙醇提取。
6.根据权利要求5所述的制备方法,其特征在于:所述乙醇浓度选自50~95%v/v。
7.权利要求1或2所述的药物组合物在制备治疗痛风或痛风所致的关节红肿热痛或关节炎的产品中的用途。
8.权利要求1或2所述的药物组合物在制备具有消肿止痛、凉血止血、活血散瘀、疏通赛米管道功效的产品中的用途。
9.权利要求1或2所述的药物组合物在制备治疗跌扑引起的瘀肿疼痛、急性软组织损伤、无名肿痛的产品中的用途。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210040885.2A CN114832045A (zh) | 2022-01-13 | 2022-01-13 | 一种治疗痛风的药物组合物及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210040885.2A CN114832045A (zh) | 2022-01-13 | 2022-01-13 | 一种治疗痛风的药物组合物及其制备方法和用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114832045A true CN114832045A (zh) | 2022-08-02 |
Family
ID=82561425
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210040885.2A Pending CN114832045A (zh) | 2022-01-13 | 2022-01-13 | 一种治疗痛风的药物组合物及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114832045A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101987123A (zh) * | 2009-08-05 | 2011-03-23 | 吉林一正药业集团有限公司 | 一种用于缓解人体疼痛的药物及其制备方法 |
CN105616637A (zh) * | 2014-10-26 | 2016-06-01 | 聂晓鸿 | 治痛风性关节炎外用的中药配方 |
CN107468768A (zh) * | 2017-09-06 | 2017-12-15 | 成都市金牛区羌医药研究所 | 一种羌药组合物及其用途 |
-
2022
- 2022-01-13 CN CN202210040885.2A patent/CN114832045A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101987123A (zh) * | 2009-08-05 | 2011-03-23 | 吉林一正药业集团有限公司 | 一种用于缓解人体疼痛的药物及其制备方法 |
CN105616637A (zh) * | 2014-10-26 | 2016-06-01 | 聂晓鸿 | 治痛风性关节炎外用的中药配方 |
CN107468768A (zh) * | 2017-09-06 | 2017-12-15 | 成都市金牛区羌医药研究所 | 一种羌药组合物及其用途 |
Non-Patent Citations (1)
Title |
---|
黄满平,等: "中药外敷治疗痛风性关节炎15例" * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wagner | The diabetic foot | |
CN101209267B (zh) | 红色诺卡氏菌细胞壁骨架在制备治疗皮肤损伤和疮疡的药物中的用途 | |
CN101991688A (zh) | 药物组合物在制备治疗糖尿病溃疡药物中的用途 | |
CN102908442B (zh) | 治疗跌打损伤的组合物及其药酒 | |
US6797285B1 (en) | Leaves of Cajanus Cajan(L.) Millsp and extract, formulation and uses thereof | |
CN114832045A (zh) | 一种治疗痛风的药物组合物及其制备方法和用途 | |
CN102240351B (zh) | 一种治疗关节炎骨质增生椎间盘突出颈椎病的中药药物 | |
RU2246959C2 (ru) | Мазь противовоспалительного и ранозаживляющего действия /варианты/ | |
CN114344385B (zh) | 一种羌医药物组合物及其制备方法和用途 | |
Shuper et al. | Varicella arthritis in a child. | |
CN111450195B (zh) | 一种治疗热痹症的中药组合物 | |
CN100438887C (zh) | 一种治疗骨折的中成药及其制备方法 | |
Shakirov | Foot postburn bent contracture deformities | |
Colen et al. | Posterior hindfoot reconstruction | |
CN102755487A (zh) | 祛湿活血中药粉 | |
CN106309992A (zh) | 一种治疗骨质增生的中药组合物 | |
Walsh et al. | Burn scar contractures & their management | |
CN101224253B (zh) | 一种治疗寒湿阻络型糖尿病足的中药组合物及其制备方法 | |
CN1141967C (zh) | 一种治疗烧烫伤的外用中药油剂 | |
CN105311571A (zh) | 一种治疗骨伤及颈肩腰腿痛的中药组合物 | |
CN111529584A (zh) | 一种治疗骨折、关节炎及急慢性软组织损伤的中药组合物及其制备方法 | |
Wang et al. | Posterior Tibial Artery Flap in Series with Medial Plantar Artery Flap for Repair of Anterior Foot Degloving Injury | |
Tecuceanu et al. | The Particularities of Using Enzymatic Debridement Therapy in Deep Burns Treatment According to Functional Regions | |
CN111671838A (zh) | 一种接骨药 | |
CN104758400A (zh) | 一种治疗风湿、关节炎的外用药酒及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220802 |